Dolutegravir-based regimen safe and effective for people taking rifampicin for TB
EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards
EACS takes steps towards a common, auditable European standard of care
Dolutegravir-based ART effective and safe for HIV-positive people taking standard TB treatment
Twice-daily dolutegravir is safe and effective when used alongside TB treatment
WHO recommends package of tests, treatment and prevention for 'urgent need' people with HIV with low CD4 counts
MDR-TB numbers could keep growing despite improved treatment
Health system navigators didn't improve ART initiation or TB treatment completion rates among people newly diagnosed with HIV in Durban
Prednisone reduces the risk of developing TB-IRIS after starting antiretroviral treatment
